Investors

Cannabis Through Art and Science

Download/Sign up

for Investor Presentation Updates

Current Market

Stock Symbol: XTRX on CSE

Press Releases

Adastra Announces Fulfillment of Distillate & Vape Cart Purchase Orders

LANGLEY, BC / ACCESSWIRE / August 12, 2020 – Adastra Labs Holdings Ltd. (CSE: XTRX) (FRANKFURT: D2EP) (“Adastra”) a Health Canada Licensed cannabis processing and analytical testing services Company, is pleased to announce the fulfillment of its purchase order for bulk distillate and an order for 30,000 vaporizing cartridges from CannMart  Inc. (“CannMart”) a majority owned subsidiary of Namaste

Read More »

Adastra Labs Holdings Ltd. Announces Submission of Sales Licence Amendment

LANGLEY, BC / ACCESSWIRE / August 5, 2020 – Adastra Labs Holdings Ltd. (CSE: XTRX) (FRANKFURT: D2EP) (“Adastra”) a  Health Canada Licensed cannabis processing and analytical testing services Company, is pleased to announce the submission of its federal sales licence amendment to Health Canada. “The submission of sales licence amendment is significant as it represents the successful operationalization of

Read More »

Adastra Announces Phyto Extractions Vape Cartridge Order

LANGLEY, BC / ACCESSWIRE / July 15, 2020 – Adastra Labs Holdings Ltd. (CSE: XTRX) (FRANKFURT: D2EP) (“Adastra”) a Health Canada Licensed cannabis processing and analytical testing services Company, is pleased to announce the receipt of a purchase order for 30,000 vaporizing cartridges from CannMart  Inc. (“CannMart”) a majority owned subsidiary of Namaste Technologies Inc. (“Namaste”) (TSX-V: N) (FRANKFURT: M5BQ)

Read More »

Adastra Closes $3.49 Million Oversubscribed Private Placement

LANGLEY, BC/ ACCESSWIRE / July 14, 2020 / Adastra Labs Holdings Ltd. (CSE: XTRX) (FRANKFURT: D2EP) (“Adastra”, “XTRX”, or the “Company”) is pleased to announce the closing of its previously announced non-brokered private placement offering (see press releases dated June 18, 2020 and June 25, 2020) issuing 11,648,001 units (the “Units”) for aggregate gross proceeds of $3,494,400.

Read More »

Adastra Increases Private Placement Financing

LANGLEY, BC/  June 25, 2020 / Adastra Labs Holdings Ltd. (CSE: XTRX) (FRANKFURT: D2EP) (“Adastra”, “XTRX”, or the “Company”) a  Health Canada Licensed cannabis processing and analytical testing services company announces that it plans to increase its previously announced private placement offering (see press release dated June 18, 2020), of units (the “Units“) at a price of $0.30

Read More »

Adastra Announces Private Placement Financing

June 18, 2020 – Adastra Labs Holdings Ltd. (CSE: XTRX) (FRANKFURT: D2EP) (“Adastra”, “XTRX”, or the “Company”) a  Health Canada Licensed cannabis processing and analytical testing company announced today that it will be conducting a non-brokered private placement of units (the “Units“) at a price of $0.30 per Unit for gross proceeds of up to $1,000,000 (the “Offering“),

Read More »

Public Filings

Contact Us

Have a question? Want more information? Looking for a partner to deliver the exceptional service you need for your future business? If you're passionate about cannabis, we'd love to hear from you.

F: 844-874-9893
E: info@adastralabs.ca

5451 275th Street 
Langley, BC, Canada, V4W 3X8

Scroll to Top